16-10532759-T-TTTTTC
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001424.6(EMP2):c.*145_*146insGAAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00737 in 124,932 control chromosomes in the GnomAD database, including 105 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.012 ( 59 hom., cov: 24)
Exomes 𝑓: 0.0024 ( 46 hom. )
Consequence
EMP2
NM_001424.6 3_prime_UTR
NM_001424.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0420
Genes affected
EMP2 (HGNC:3334): (epithelial membrane protein 2) This gene encodes a tetraspan protein of the PMP22/EMP family. The encoded protein regulates cell membrane composition. It has been associated with various functions including endocytosis, cell signaling, cell proliferation, cell migration, cell adhesion, cell death, cholesterol homeostasis, urinary albumin excretion, and embryo implantation. It is known to negatively regulate caveolin-1, a scaffolding protein which is the main component of the caveolae plasma membrane invaginations found in most cell types. Through activation of PTK2 it positively regulates vascular endothelial growth factor A. It also modulates the function of specific integrin isomers in the plasma membrane. Up-regulation of this gene has been linked to cancer progression in multiple different tissues. Mutations in this gene have been associated with nephrotic syndrome type 10 (NPHS10). [provided by RefSeq, Mar 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 16-10532759-T-TTTTTC is Benign according to our data. Variant chr16-10532759-T-TTTTTC is described in ClinVar as [Likely_benign]. Clinvar id is 1706774.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0124 (769/61910) while in subpopulation AFR AF= 0.0225 (278/12330). AF 95% confidence interval is 0.0204. There are 59 homozygotes in gnomad4. There are 338 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 59 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EMP2 | NM_001424.6 | c.*145_*146insGAAAA | 3_prime_UTR_variant | 5/5 | ENST00000359543.8 | NP_001415.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EMP2 | ENST00000359543 | c.*145_*146insGAAAA | 3_prime_UTR_variant | 5/5 | 1 | NM_001424.6 | ENSP00000352540.3 |
Frequencies
GnomAD3 genomes AF: 0.0124 AC: 769AN: 61898Hom.: 59 Cov.: 24
GnomAD3 genomes
AF:
AC:
769
AN:
61898
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00241 AC: 152AN: 63022Hom.: 46 Cov.: 3 AF XY: 0.00252 AC XY: 79AN XY: 31366
GnomAD4 exome
AF:
AC:
152
AN:
63022
Hom.:
Cov.:
3
AF XY:
AC XY:
79
AN XY:
31366
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0124 AC: 769AN: 61910Hom.: 59 Cov.: 24 AF XY: 0.0116 AC XY: 338AN XY: 29062
GnomAD4 genome
AF:
AC:
769
AN:
61910
Hom.:
Cov.:
24
AF XY:
AC XY:
338
AN XY:
29062
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2021 | See Variant Classification Assertion Criteria. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at